Group One Trading’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Hold |
0
| – | – | – | 3793 |
|
2025
Q1 | – | Hold |
0
| – | – | – | 3673 |
|
2024
Q4 | – | Hold |
0
| – | – | – | 3518 |
|
2024
Q3 | – | Hold |
0
| – | – | – | 3178 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 3226 |
|
2024
Q1 | – | Sell |
-78,951
| Closed | -$186K | – | 3338 |
|
2023
Q4 | $186K | Buy |
78,951
+12,781
| +19% | +$30K | ﹤0.01% | 762 |
|
2023
Q3 | $123K | Buy |
66,170
+26,097
| +65% | +$48.5K | ﹤0.01% | 869 |
|
2023
Q2 | $105K | Sell |
40,073
-55,785
| -58% | -$146K | ﹤0.01% | 839 |
|
2023
Q1 | $156K | Buy |
95,858
+41,851
| +77% | +$68.2K | ﹤0.01% | 740 |
|
2022
Q4 | $71.8K | Buy |
+54,007
| New | +$71.8K | ﹤0.01% | 998 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 3334 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 3374 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 3359 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 3388 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 3290 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 3149 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 2959 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 2678 |
|
2020
Q3 | – | Sell |
-2,180
| Closed | -$6K | – | 2558 |
|
2020
Q2 | $6K | Buy |
2,180
+1,700
| +354% | +$4.68K | ﹤0.01% | 1220 |
|
2020
Q1 | $1K | Sell |
480
-300
| -38% | -$625 | ﹤0.01% | 1306 |
|
2019
Q4 | $6K | Hold |
780
| – | – | ﹤0.01% | 1169 |
|
2019
Q3 | $8K | Buy |
+780
| New | +$8K | ﹤0.01% | 1124 |
|